“In my dreams I would have the perfect AI generated email first thing every morning with the most substantive articles of interest to me in foreign affairs, domestic policy, business, tech and media distilled with on point commentary. Oh wait! I already have it with News Items.” — Annie Lamont, co-founder of Oak HC/FT, a leading venture capital firm.
1. Tens of millions of people in the United States struggle with obstructive sleep apnea, a condition that occurs when the throat muscles narrow during sleep, leading to temporary pauses in breathing that can cause people to snore and jolt awake, gasping for air. Poor sleep can leave people feeling exhausted, irritable and unfocused during the day. If left untreated, sleep apnea can increase the risk for serious conditions like high blood pressure, Type 2 diabetes, heart attack and stroke. For decades, the primary treatment for sleep apnea has been continuous positive airway pressure (or CPAP). Before bed, those with the condition put on a face mask that is connected to a CPAP machine, which keeps the airway open by forcing air into it. The machines are effective, but many find them so noisy, cumbersome or uncomfortable that they end up abandoning them. Now, a more appealing option may be on the way, according to a news release from Apnimed, a pharmaceutical company focused on treating sleep apnea. On Wednesday, the company announced a second round of positive Phase 3 clinical trial results for a first-of-its-kind oral pill that can be taken just before bedtime to help keep a person’s airway open. Sleep experts say that what they’re seeing in reports so far makes them think the pill could be a game changer. (Source: nytimes.com)
Keep reading with a 7-day free trial
Subscribe to News Items to keep reading this post and get 7 days of free access to the full post archives.